Nymox Pharmaceutical Corporation announced effective June 28, 2022, accepted the resignation of Erik Danielsen as Chief Financial Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | +7.14% |
|
-52.63% | -84.75% |
1st Jan change | Capi. | |
---|---|---|
-84.75% | 8.4M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Resignation of Erik Danielsen as Chief Financial Officer